Kuros Bioscience Ltd. financial statements, including revenue, expenses, profit, and loss
The total revenue of CSBTF for the last semiannual is 35.42 M USD, and it's 44.08% higher compared to the previous semiannual. The net income of H1 24 is -234.69 k USD.